Compare of optic coherence tomography parameters in recreational synthetic tetrahydrocannabinol use and healthy control

References

• Brust JCM. Neurologic complications of illicit drug abuse. Continuum. 2014;20(3 Neurology of Systemic Disease):642–656. doi: 10.1212/01.CON.0000450971.99322.cd.
   PubMedGoogle Scholar
• Asbridge M, Hayden JA, Cartwright JL. Acute cannabis consumption and motor vehicle collision risk: systematic review of observational studies and meta-analysis. BMJ. 2012;344:e536. doi: 10.1136/bmj.e536.
   PubMed Web of Science ®Google Scholar
• Harris CR, Brown A. Synthetic cannabinoid intoxication: a case series and review. J Emerg Med. 2013;44(2):360–366. doi: 10.1016/j.jemermed.2012.07.061.
   PubMed Web of Science ®Google Scholar
• Seely KA, Lapoint J, Moran JH, et al. Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids. Prog Neuropsychopharmacol Biol Psychiatry. 2012;39(2):234–243. doi: 10.1016/j.pnpbp.2012.04.017.
   PubMed Web of Science ®Google Scholar
• Maren H-C, Kneisel S, Szabo B. Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings.2013;108(3):534–544.
   Google Scholar
• Spaide RF, Koizumi H, Pozzoni MC, et al. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008;146(4):496–500. doi: 10.1016/j.ajo.2008.05.032.
   PubMed Web of Science ®Google Scholar
• Wolff V, Lauer V, Rouyer O, et al. Cannabis use, ischemic stroke, and multifocal intracranial vasoconstriction: a prospective study in 48 consecutive young patients -Stroke. 2011;42(6):1778–1780.
   Google Scholar
• Onaran Z, Akbulut Y, Tursun S, et al. Purtscher-like retinopathy associated with synthetic cannabinoid (bonzai) use. Turk J Ophthalmol. 2019;49(2):114–116. doi: 10.4274/tjo.galenos.2018.67670.
   PubMedGoogle Scholar
• Malik K, Kommana S, Paul J, et al. Synthetic cannabinoid induced ocular self-injury. Orbit. 2021;40(4):326–328. doi: 10.1080/01676830.2020.1781199.
   PubMedGoogle Scholar
• Bielory L, Tabliago NRA. Flavonoid and cannabinoid impact on the ocular surface. Curr Opin Allergy Clin Immunol. 2020;20(5):482–492. doi: 10.1097/ACI.0000000000000673.
   PubMed Web of Science ®Google Scholar
• Aksel G, Bozan O, Kayaci M, et al. Rising threat; bonsai. Turk J Emerg Med. 2015;15(2):75–78. doi: 10.5505/1304.7361.2015.80388.
   PubMedGoogle Scholar
• Munro S, Thomas KL, Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature. 1993;365(6441):61–65. doi: 10.1038/365061a0.
   PubMed Web of Science ®Google Scholar
• Pertwee RG. Pharmacology of cannabinoid receptor ligands. CMC. 1999;6(8):635–664. doi: 10.2174/0929867306666220401124036.
   Google Scholar
• Hájos N, Freund TF. Distinct cannabinoid sensitive receptors regulate hippocampal excitation and inhibition. Chem Phys Lipids. 2002;121(1-2):73–82. doi: 10.1016/s0009-3084(02)00149-4.
   PubMed Web of Science ®Google Scholar
• Spaderna M, Addy PH, D’Souza DC. Spicing things up: synthetic cannabinoids. Psychopharmacology). 2013;228(4):525–540. doi: 10.1007/s00213-013-3188-4.
   PubMed Web of Science ®Google Scholar
• Porcella A, Casellas P, Gessa GL, et al. Cannabinoid receptor CB1 mRNA is highly expressed in the rat ciliary body: implications for the antiglaucoma properties of marihuana. Brain Res Mol Brain Res. 1998;58(1-2):240–245. doi: 10.1016/s0169-328x(98)00105-3.
   PubMedGoogle Scholar
• Stamer WD, Golightly SF, Hosohata Y, et al. Cannabinoid CB(1) receptor expression, activation and detection of endogenous ligand in trabecular meshwork and ciliary process tissues. Eur J Pharmacol. 2001;431(3):277–286. doi: 10.1016/s0014-2999(01)01438-8.
   PubMed Web of Science ®Google Scholar
• Straiker AJ, Maguire G, Mackie K, et al. Localization of cannabinoid CB1 receptors in the human anterior eye and retina. Invest Ophthalmol Visual Sci. 1999;40:2442–2448.
   PubMed Web of Science ®Google Scholar
• Middleton TP, Protti DA. Cannabinoids modulate spontaneous synaptic activity in retinal ganglion cells. Vis Neurosci. 2011;28(5):393–402. doi: 10.1017/S0952523811000198.
   PubMed Web of Science ®Google Scholar
• Struik D, Sanna F, Fattore L. The modulating role of sex and anabolic-androgenic steroid hormones in cannabinoid sensitivity. Front Behav Neurosci. 2018;12:249. doi: 10.3389/fnbeh.2018.00249.
   PubMed Web of Science ®Google Scholar
• Schwitzer T, Schwan R, Angioi-Duprez K, et al. The cannabinoid system and visual processing: a review on experimental findings and clinical presumptions. Eur Neuropsychopharmacol. 2015;25(1):100–112. doi: 10.1016/j.euroneuro.2014.11.002.
   PubMed Web of Science ®Google Scholar
• Zobor D, Strasser T, Zobor G, et al. Ophthalmological assessment of cannabis-induced persisting perception disorder: is there a direct retinal effect? Doc Ophthalmol. 2015;130(2):121–130. doi: 10.1007/s10633-015-9481-2.
   PubMed Web of Science ®Google Scholar
• Dayi A, Dayi Ö, Kurt E, et al. [Optical coherence tomography findings in cannabis users]. Turk Psikiyatri Derg. 2020;31:239–243.
   PubMed Web of Science ®Google Scholar
• Kalenderoglu A, Orum MH, Karadag AS, et al. Increases in retinal nerve fiber layer thickness may represent the neuroprotective effect of cannabis: an optical coherence tomography study. J Addict Dis. 2020;38(3):280–290. doi: 10.1080/10550887.2020.1754109.
   PubMed Web of Science ®Google Scholar
• Lax P, Esquiva G, Altavilla C, et al. Neuroprotective effects of the cannabinoid agonist HU210 on retinal degeneration. Exp Eye Res. 2014;120:175–185. doi: 10.1016/j.exer.2014.01.019.
   PubMed Web of Science ®Google Scholar
• Kokona D, Georgiou P-C, Kounenidakis M, et al. Endogenous and synthetic cannabinoids as therapeutics in retinal disease. Neural Plast. 2016; 2016), :8373020. doi: 10.1155/2016/8373020.
   PubMed Web of Science ®Google Scholar
• Schwitzer T, Schwan R, Angioi-Duprez K, et al. The endocannabinoid system in the retina: from physiology to practical and therapeutic applications. Neural Plast. 2016; 2016), :2916732. doi: 10.1155/2016/2916732.
   PubMed Web of Science ®Google Scholar
• Maruko I, Iida T, Sugano Y, et al. Subfoveal choroidal thickness after treatment of Vogt-Koyanagi-Harada disease. Retina. 2011;31(3):510–517. doi: 10.1097/IAE.0b013e3181eef053.
   PubMed Web of Science ®Google Scholar
• Sezer T, Altınışık M, Koytak İA, et al. The choroid and optical coherence tomography. Turk J Ophthalmol. 2016;46(1):30–37. doi: 10.4274/tjo.10693.
   PubMedGoogle Scholar
• Vance SK, Imamura Y, Freund KB. The effects of sildenafil citrate on choroidal thickness as determined by enhanced depth imaging optical coherence tomography. Retina. 2011;31(2):332–335. doi: 10.1097/IAE.0b013e3181eef0ae.
   PubMed Web of Science ®Google Scholar
• Hohmann N, Mikus G, Czock D. Effects and risks associated with novel psychoactive substances: mislabeling and sale as bath salts, spice, and research chemicals. Dtsch Arztebl Int. 2014;111:139–147.
   PubMed Web of Science ®Google Scholar
• Riederer AM, Campleman SL, Carlson RG, et al. Acute poisonings from synthetic Cannabinoids - 50 U.S toxicology ınvestigators consortium registry sites, 2010–2015. MMWR Morb Mortal Wkly Rep. 2016;65:692–695.
   PubMed Web of Science ®Google Scholar